Toxic keratolysis from combined use of nonsteroid anti-inflammatory drugs and topical steroids following vitreoretinal surgery

European Journal of Ophthalmology

Volumn 16, Issue 4, 2006, Pages 582-587

  Alvarez M T ^a   Figueroa, Marta S ^a,b   Teus, M A ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b VISSUM Corporacion Oftalmologica   (Spain)

Author keywords

Nonsteroid anti inflammatory drugs; NSAIDs; Steroids; Toxic keratolysis; Vitrectomy; Vitreoretinal surgery

Indexed keywords

ACETAZOLAMIDE; CHLORTETRACYCLINE; CIPROFLOXACIN; CYCLOPENTOLATE; FLUOROMETHOLONE; GENTAMICIN; ISOPTOFLUCON; KETOROLAC; KETOROLAC TROMETAMOL; NEOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; OFTACILOX; POLYMYXIN B; PREDNISOLONE ACETATE; PREDNISONE; STEROID; DRUG DERIVATIVE; GLUCOCORTICOID; PREDNISOLONE;

ADULT; AGED; ARTICLE; CASE REPORT; CATARACT EXTRACTION; CHOROID HEMORRHAGE; CILIARY DISK; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEA LESION; CORNEA STROMA; CORNEA ULCER; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIRETINAL MEMBRANE; EYELID CLOSURE; FEMALE; FOLLOW UP; HUMAN; KERATOLYSIS; MALE; PRIORITY JOURNAL; RETINA SURGERY; SCAR FORMATION; SUBRETINAL NEOVASCULARIZATION; SURGICAL DRAINAGE; UVEA DISEASE; VISUAL ACUITY; VITRECTOMY; ATROPHY; CHEMICALLY INDUCED DISORDER; CORNEA; DRUG COMBINATION; DRUG EFFECT; MIDDLE AGED; PATHOLOGY; PHACOEMULSIFICATION;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATROPHY; CHOROIDAL NEOVASCULARIZATION; CORNEA; CORNEAL ULCER; CYCLOPENTOLATE; DRUG THERAPY, COMBINATION; EPIRETINAL MEMBRANE; FEMALE; GLUCOCORTICOIDS; HUMANS; KETOROLAC; MALE; MIDDLE AGED; NEOMYCIN; PHACOEMULSIFICATION; POLYMYXIN B; PREDNISOLONE; UVEAL DISEASES; VITRECTOMY;

EID: 33750611300     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210601600413     Document Type: Article

References (41)

1. Nichols J, Snyder RW. Topical nonsteroidal anti-inflammatory agents in ophthalmology. Curr Opin Ophthalmol 1998; 9: 40-4.
2. Flach AJ, Jampol LM, Weinberg D, et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 1991; 112: 514-9.
3. Italian Diclofenac Study Group. Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. J Cataract Refract Surg 1997; 23: 1183-9.
4. Weisz JM, Bressler NM, Bressler SB, Schachat AP. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction. Ophthalmology 1999; 106: 1656-9.
5. Miyake K, Masuda K, Shirato S, et al. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial. Jpn J Ophthalmol 2000; 44: 58-67.
6. Tinkelman DG, Rupp G, Kaufman H, et al. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis. Surv Ophthalmol 1993; 38: 133-40.
7. Tauber J, Raizman MB, Ostrov CS, et al. A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis. J Ocul Pharmacol Ther 1998; 14: 137-45.
8. Stewart R, Grosserode R, Cheetham JK, Rosenthal A. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery. Clin Ther 1999; 21: 723-32.
9. Frucht-Pery J, Siganos CS, Solomon A, et al. Topical indomethacin solution versus dexamethasone solution for treatment of inflamed pterygium and pinguecula: a prospective randomized clinical study. Am J Ophthalmol 1999; 127: 148-52.
10. Kaiser PK, Pineda R II. A study of topical nonsteroidal anti-inflammatory drops and no pressure patching in the treatment of corneal abrasions. Ophthalmology 1997; 104: 1353-9.
11. Szucs PA, Nashed AH, Allegra JR, Eskin B. Safety and efficacy of diclofenac ophthalmic solution in the treatment of corneal abrasions. Ann Emerg Med 2000; 35: 131-7.
12. Goethals M, Missotten L. Efficacy and safety of indomethacin 0.1% versus flurbiprofen 0.03% eyedrops in inflammation after argon laser trabeculoplasty. Doc Ophthalmol 1994; 85: 287-93.
13. Flach AJ, Dolan BJ, Donahue ME, et al. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Ophthalmology 1998; 105: 1775-9.
14. Heier J, Cheetham JK, Degryse R, et al. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Am J Ophthalmol 1999; 127: 253-9.
15. Simone JN, Pendelton RA, Jenkins JE. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery. J Cataract Refract Surg 1999; 25: 699-704.
16. 10. Kent AR, Dubiner HB, Whkaker R, et al. The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C. Ophthalmic Surg Lasers 1998; 29: 562-9.
17. Weinstock VM, Weinstock DJ, Weinstock SJ. Diclofenac and ketorolac in the treatment of pain after photorefractive keratectomy. J Refract Surg 1996; 12: 792-4.
18. Rajpal RK, Cooperman BB. Analgesic efficacy and safety of ketorolac after photorefractive keratectomy. J Refract Surg 1999; 15: 661-7.
19. Apt L, Voo I, Isenberg SJ. A randomized clinical trial of the nonsteroidal eyedrop diclofenac after strabismus surgery. Ophthalmology 1998; 105: 1449-52; discussion by SP Kraft, 1453-4.
20. Fekrat S, Marsh MJ, Elsing SH, et al. Intraoperative ketorolac and eye pain after vitreoretinal surgery: a prospective, randomized, placebo-controlled study. Retina 2003; 23: 8-13.
21. Sun R, Gimbel HV. Effects of topical ketorolac and diclofenac on normal corneal sensation. J Refract Surg 1997; 13: 158-61.
22. Shimazaki J, Saito H, Yang H-Y, et al. Persistent epithelial defects following penetrating keratoplasty: an adverse effect of diclofenac eyedrops. Cornea 1995; 14: 623-7.
23. Gills JP. Voltaren associated with medication keratitis [letter]. J Cataract Refract Surg 1994; 20: 110.
24. Sher NA, Krueger RR, Teal P, et al. Role of topical corticosteroids and nonsteroidal antiinflammatory drugs in the etiology of stromal infiltrates after excimer photorefractive keratectomy [letter]. J Refract Corneal Surg 1994; 10: 587-8.
25. Probst LE, Machat JJ. Corneal subepithelial infiltrates following photorefractive keratectomy [letter]. J Cataract Refract Surg 1996; 22: 281.
26. Congdon NG, Scheind OD, von Kulajta P, et al. Corneal complications associated with topical ophthalmic use of nonsteroidal anti-inflammatory drugs. J Cataract Refract Surg 2001; 27: 622-31.
27. Flach AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol 1992; 36: 259-84.
28. Sheehan GJ, Kutzner MR, Chin WD. Acute asthma attack due to ophthalmic indomethacin [letter]. Ann Intern Med 1989; 111: 337-8.
29. Lin JC, Rapuano CJ, Laibson PR, et al. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol 2000; 118: 1129-32.
30. O'Brien TP, Li QJ, Sauerburger F, et al. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use. Ophthalmology 2001; 108: 656-9.
31. Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology 2001; 108: 936-44.
32. Flach AJ. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans Am Ophthalmol Soc 2001; 99: 205-12.
33. Gabison EE, Chastang P, Menashi S, et al. Late corneal perforation after photorefractive keratectomy associated with topical diclofenac. Ophthalmology 2003; 110: 1623-1.
34. Yamada M, Ogata M, Kawai M, et al. Topical diclofenac sodium decreases the substance P content of tears. Arch Ophthalmol 2002; 120: 51-4.
35. Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res 1998; 290(Suppl): S12-23.
36. Lu KL, Wee WR, Sakamoto T, McDonnell PJ. Comparison of in vitro antiproliferative effects of steroids and nonsteroidal anti-inflammatory drugs on human keratocytes. Cornea 1996; 15: 185-90.
37. Hersh PS, Rice BA, Baer JC, et al. Topical nonsteroidal agents and corneal wound healing. Arch Ophthalmol 1990; 108: 577-83.
38. Simmons DL, Botting RM, Robertson PM, et al. Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroidal anti-inflammatory drugs. Proc Natl Acad Sci USA 1999; 96: 3275-80.
39. Lu X, Xie W, Reed D, et al. Nonsteroidal anti-inflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblast. Proc Natl Acad Sci USA 1995; 92: 7961-5.
40. Price FW. New pieces for the puzzle: nonsteroidal anti-inflammatory drugs and cornea ulcers [guest editorial]. J Cataract Refract Surg 2000; 26: 1263-4.
41. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol 1997; 49 (Suppl): S15-9.